HLA class II haplotype DRB1*04-DQB1*0301 contributes to risk of familial generalized vitiligo and arly disease onset

Pigment Cell Research

Volumn 19, Issue 1, 2006, Pages 51-57

  Fain, Pamela R ^a,b   Babu, Sunanda R ^b   Bennett, Dorothy C ^c   Spritz, Richard A ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO DENVER   (United States)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Association; Autoimmune polyendocrine syndrome; HLA; Multiple autoimmune disease; Vitiligo

Indexed keywords

HLA ANTIGEN CLASS 2;

ALLELE; ARTICLE; AUTOIMMUNE DISEASE; AUTOINFLAMMATORY DISEASE; CASE CONTROL STUDY; CAUCASIAN; CHROMOSOME; CONTROLLED STUDY; DISEASE COURSE; EUROPEAN AMERICAN; GENE FREQUENCY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; ONSET AGE; PARENT; RISK; VITILIGO;

ADOLESCENT; ADULT; AGE OF ONSET; CASE-CONTROL STUDIES; GENE FREQUENCY; GENES, MHC CLASS II; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MEMBRANE GLYCOPROTEINS; VITILIGO;

EID: 33645105491     PISSN: 08935785     EISSN: 16000749     Source Type: Journal    
DOI: 10.1111/j.1600-0749.2005.00279.x     Document Type: Article

References (49)

1. al-Fouzan A. al-Arbash M. Fouad F. Kaaba S.A. Mousa M.A. al-Harbi S.A. 1995 Study of HLA class I/IL and T lymphocyte subsets in Kuwaiti vitiligo patients Eur. J. Immunogenet. 22 209 213
2. Alkhateeb A. Stetler G.L. Old W. et al. 2002 Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2 Hum. Mol. Genet. 11 661 667
3. Alkhateeb A. Fain P.R. Thody A. Bennett D.C. Spritz R.A. 2003 Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families Pigment Cell Res. 16 208 214
4. Ando I. Chi H.-I. Nakagawa H. Otsuka F. 1993 Difference in clinical features and HLA antigens between familial and non-familial vitiligo of non-segmental type Br. J. Dermatol. 129 408 410
5. Buc M. Fazekasova H. Cechova E. Hegyi E. Kolibasova K. Ferencik S. 1998 Occurrence rates of HLA-DRB1, HLA-DQB1, and HLA-DPB1 alleles in patients suffering from vitiligo Eur. J. Dermatol. 8 13 15
6. Bugawan T.L. Klitz W. Blair A. Erlich H.A. 2000 High-resolution HLA class I typing in the CEPH families: analysis of linkage disequilibrium among HLA loci Tissue Antigens 56 392 404
7. Carrington M. Stephens J.C. Klitz W. Begovich A.B. Erlich H.A. Mann D. 1994 Major histocompatibility complex class II haplotypes and linkage disequilibrium values observed in the CEPH families Hum. Immunol. 41 234 240
8. Chen J.J. Huang W. Gui J.P. et al. 2005 A novel linkage to generalized vitiligo on 4q13-q21 identified in a genomewide linkage analysis of Chinese families Am. J. Hum. Genet. 76 1057 1065
9. Clayton D. 1999 A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission Am. J. Hum. Genet. 65 1170 1177
10. Cordell H.J. Clayton D.G. 2002 A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes Am. J. Hum. Genet. 70 124 141
11. Darke C. Guttridge M.G. Thompson J. McNamara S. Street J. Thomas M. 1998 HLA class I (A,B) and II (DR,DQ) gene and haplotype frequencies in blood donors from Wales Exp. Clin. Immunogenet. 15 69 83
12. Dudbridge F. 2003 Pedigree disequilibrium tests for multilocus haplotypes Genet. Epidemiol. 25 115 121
13. Dunston G.M. Halder R.M. 1990 Vitiligo is associated with HLA-DR4 in black patients. A preliminary report Arch. Dermatol. 126 56 60
14. Fain P.R. Gowan K. LaBerge G.S. Alkhateeb A. Stetler G.L. Talbert J. Bennett D.C. Spritz R.A. 2003 A genomewide screen for generalized vitiligo: confirmation of AIS1 on chromosome 1p31 and evidence for additional susceptibility loci Am. J. Hum. Genet. 72 1560 1564
15. Finco O. Cuccia M. Martinetti M. Ruberto G. Orecchia G. Rabbiosi G. 1991 Age of onset of vitiligo: relationship with HLA supratypes Clin. Genet. 39 48 54
16. Foley L.M. Lowe N.J. Misheloff E. Tiwari J.L. 1983 Association of HLA-DR4 with vitiligo J. Acad. Dermatol. 8 39 40
17. Gregersen P.K. 2003 Teasing apart the complex genetics of human autoimmunity: lessons from rheumatoid arthritis Clin. Immunol. 107 1 9
18. Hann S.-K. Nordlund J.J. 2000 Vitiligo Oxford Blackwell Science
19. Hirschhorn J.N. Lohmueller K. Byrne E. Hirschhorn K. 2002 A comprehensive review of genetic association studies Genet. Med. 4 45 61
20. Klitz W. Maiers M. Spellman S. Baxter-Lowe L.A. Schmeckpeper B. Williams T.M. Fernandez-Vina M. 2003 New HLA haplotype frequency reference standards: high-resolution and large sample typing of HLA DR-DQ haplotypes in a sample of European Americans Tissue Antigens 62 296 307
21. LaBerge G. Mailloux C.M. Gowan K. Holland P. Bennett D.C. Fain P.R. Spritz R.A. 2005 Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo Pigment Cell Res. 18 300 305
22. Lorini R. Orecchia G. Martinetti M. Dugoujon J.M. Cuccia M. 1992 Autoimmunity in vitiligo: relationship with HLA, Gm and Km polymorphisms Autoimmunity 11 255 260
23. Majumder P.P. 2000 Genetics and prevalence of vitiligo vulgaris In Vitiligo Hann S.-K. Nordlund J.J. eds Oxford Blackwell Science pp 18 20
24. Majumder P.P. Nordlund J.J. Nath S.K. 1993 Pattern of familial aggregation of vitiligo Arch. Dermatol. 129 994 998
25. Metzker A. Zamir R. Gazit E. David M. Feuerman E.J. 1980 Vitiligo and HLA system Dermatologica 160 100 105
26. Myhre A.G. Undlien D.E. Lovas K. Uhlving S. Nedrebo B.G. Fougner K.J. Trovik T. Sorheim J.I. Husebye E.S. 2002 Autoimmune adrenocortical failure in Norway autoantibodies and human leukocyte antigen class II associations related to clinical features J. Clin. Endocrinol. Metab. 87 618 623
27. Newton J.L. Harney S.M. Wordsworth B.P. Brown M.A. 2004 A review of the MHC genetics of rheumatoid arthritis Genes Immun. 5 151 157
28. Noble J.A. Valdes A.M. Cook M. Klitz W. Thomson G. Erlich H.A. 1996 The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families Am. J. Hum. Genet. 59 1134 1148
29. Ongenae K. Van Geel N. Naeyaert J.-N. 2003 Evidence for an autoimmune pathogenesis of vitiligo Pigment Cell Res. 16 90 100
30. Orecchia G. Perfetti L. Malagoli P. Borghini F. Kipervarg K. 1992 Vitiligo is associated with a significant increase in HLA-A30, Cw6 and DQw3 and a decrease in C4AQ0 in Northern Italian patients Dermatology 185 123 127
31. Peterson P. Uibo R. Krohn K.J. 2000 Adrenal autoimmunity: results and developments Trends Endocrinol. Metab. 11 285 290
32. Poloy A. Tibor L. Kramer J. Anh-Tuan N. Kraszits E. Medgyessy I. Fust G. Stenszky V. Farid N.R. 1991 HLA-DR1 is associated with vitiligo Immunol. Lett. 27 59 62
33. Pozzilli P. Di Mario U. 2001 Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult): definition, characterization, and potential prevention Diabetes Care 24 1460 1467
34. Rahman P. Elder J.T. 2005 Genetic epidemiology of psoriasis and psoriatic arthritis Ann. Rhemat. Dis. 64 Suppl. 2 ii37 ii39
35. Redondo M.J. Fain P.R. Eisenbarth G.S. 2001 Genetics of type 1A diabetes Recent Prog. Horm. Res. 56 69 89
36. Retornaz G. Betuel H. Ortonne J.P. Thivolet J. 1976 HL-A antigens and vitiligo Br. J. Dermatol. 95 173 175
37. Schallreuter K.U. Levenig C. Kuhnl P. Loliger C. Hohl-Tehari M. Berger J. 1993 Histocompatibility antigens in vitiligo: Hamburg study on 102 patients from northern Germany Dermatology 187 186 192
38. Simmonds M.J. Gough S.C. 2004 Unravelling the genetic complexity of autoimmune thyroid disease: HLA, CTLA-4 and beyond Clin. Exp. Immunol. 136 1 10
39. Spielman R.S. McGinnis R.E. Ewens W.J. 1993 Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM) Am. J. Hum. Genet. 52 506 516
40. Spritz R.A. Gowan K. Bennett D.C. Fain P.R. 2004 Novel vitiligo susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis Am. J. Hum. Genet. 74 188 191
41. Tastan H.B. Akar A. Orkunoglu F.E. Arca E. Inal A. 2004 Association of HLA class I antigens and HLA class II alleles with vitiligo in a Turkish population Pigment Cell Res. 17 181 184
42. Venkataram M.N. White A.G. Leeny W.A. al Suwaid A.R. Daar A.S. 1995 HLA antigens in Omani patients with vitiligo Clin. Exp. Dermatol. 20 35 37
43. Venneker G.T. de Waal L.P. Westerhof W. D'Amaro J. Schreuder G.M. Asghar S.S. 1993 HLA associations in vitiligo patients in the Dutch population Dis. Markers 11 187 190
44. Yu C.Y. Whitacre C.C. 2004 Sex, MHC and complement C4 in autoimmune diseases Trends Immunol. 25 694 699
45. Yu L. Brewer K.W. Gates S. et al. 1999 DRB1*04 and DQ alleles: expression of 21-hydroxylase autoantibodies and risk of progression to Addison's disease J. Clin. Endocrinol. Metab. 84 328 335
46. Yunis E.J. Larsen C.E. Fernandex-Vina M. Awdeh Z.L. Romero T. Hansen J.A. Alper C.A. 2003 Inheritable variable sizes of DNA stretches in the human MHC: conserved extended haplotypes and their fragments or blocks Tissue Antigens 62 1 20
47. Zamani M. Spaepen M. Sghar S.S. Huang C. Westerhof W. Nieuweboer-Krobotova L. Cassiman J.J. 2001 Linkage and association of HLA class II genes with vitiligo in a Dutch population Br. J. Dermatol. 145 90 94
48. Zettnig G. Tanew A. Fischer G. Mayr W. Dudczak R. Weissel M. 2003 Autoimmune diseases in vitiligo: do anti nuclear antibodies decrease thyroid volume? Clin. Exp. Immunol. 131 347 354
49. Zhang X.-J. Liu H.-S. Liang Y.-H. et al. 2004 Association of HLA class I alleles with vitiligo in Chinese Hans J. Dermatol. Sci. 35 165 168